ONTO INNOVATION INC. (ONTO): what the price assumes
In the published model solve dated 2026-Q2, anchored at $275.75, ONTO INNOVATION INC. (ONTO) is priced for today's economics sustained for ~31.2 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.
Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/ONTO
Headline
| Field | Value |
|---|---|
| Ticker | ONTO |
| Company | ONTO INNOVATION INC. |
| Current price | $275.75/sh |
| Composition | Systems and software 84% / Parts 8% / Services 7% |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Must persist for | 31.2y |
| Multiple paid | 130x operating income |
Solve inputs: computed at a 13.9% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~4 years.
Reconcile: at the x-ray's 9.3% required return this reads ~16.9 years; the models below use their own rates.
How unusual the bet is: elevated
| Reference | Value |
|---|---|
| vs own history | +0.66σ |
| sustained it ~10 years at this level | 14% |
| implied end-window share | 1% |
Valuation X-Ray
Every valuation family lands below the price. The price therefore sits beyond what those standard frames encode.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 14.75x | 4 | expensive |
| Earnings | 8.71x | 4 | expensive |
| Relative | 5.35x | 3 | expensive |
| Growth | 3.55x | 3 | expensive |
Families that call it expensive: Asset, Earnings, Relative, Growth
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.2%); the inversion above states its own rate.
Per-Model Detail (n=14)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $42.31 | 6.52x | yes | FCF base $0.2B, growth 0% (input: historical growth), terminal g 0.5%, WACC 9.2%, 5yr projection |
| DCF Exit Multiple | Growth | $152.40 | 1.81x | yes | Exit EV/EBITDA: 117.1x / 119.1x / 121.1x (bear / base = today's held flat / bull), 5yr |
| Relative Valuation | Relative | $74.52 | 3.70x | yes | P/E 39.6x (blended: static sector reference 18x + trailing (TTM) 130x), scenarios: 33.4x / 39.6x / 45.8x (bear / base = reference held flat / bull), EV/EBITDA 26.4x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $23.01 | 11.98x | yes | BV/sh $42.64, ROE (TTM) 5.0%, ke 9.3% |
| Two-Stage Excess Return | Asset | $15.75 | 17.51x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $77.71 | 3.55x | yes | Rev $1.0B, growth 0% (input: historical growth; tapered), Terminal P/S: 6.8x / 8.0x / 9.2x (bear / base = today's held flat / bull, cap 8x) |
| Growth-Adjusted P/E | Relative | — | — | no | — |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $17.40 | 15.85x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $0.10B × (1−11%) / WACC 9.2% → EPV (no growth) |
| Residual Income | Asset | $14.91 | 18.49x | yes | BV $42.64 + 5yr PV of (ROE (TTM) 5.0% − Kₑ 9.3%) × BV; BV grows 3.2%/yr |
| Graham Number | Asset | $45.42 | 6.07x | yes | √(22.5 × EPS $2.15 × BVPS $42.64) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $31.43 | 8.77x | yes | EBITDA $0.11B × sector EV/EBITDA 12.0x |
| FCF Yield | Earnings | $55.68 | 4.95x | yes | FCF $238.8M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $49.66 | 5.55x | yes | SBC-adj FCF $0.21B (FCF $0.24B − SBC $0.03B) capitalized at Kₑ |
| Ben Graham Formula | Earnings | $1.80 | 153.19x | yes | EPS $2.15 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median) |
| ROIC-Justified P/B | Asset | $7.11 | 38.78x | yes | BV $42.64 × (ROIC 1.5% / WACC 9.2%) (excluded from median) |
| P/Sales Sector | Relative | $51.53 | 5.35x | yes | Revenue $1.03B × sector P/S 2.5x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | $23.24 | 11.87x | yes | EPS $2.15 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Economic-Unit Decomposition (Sum Of The Parts)
Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.
| Unit | Role | Valuation basis | Revenue | Reported profit | Value evidence | Status |
|---|---|---|---|---|---|---|
| Process characterization metrology, inspection, lithography & software | operating | enterprise | 1.0B reported-currency | — | withheld | unresolved no unit value |
No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.
Solvency
| Field | Value |
|---|---|
| Net cash | $654.2m |
| Net debt / NOPAT (after-tax) | -7.14x (net cash) |
| Net debt / operating income (pre-tax) | -6.33x (net cash) |
| Share count CAGR (dilution) | 0.0% |
| Burning cash | no |
Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.
Bullet Takeaways
The trajectory is what carries Onto. Q1 2026 brought record revenue of $292 million, nearly 10% sequential growth and above guidance, with EPS of $1.42 and management guiding full-year revenue growth above 30%. Margins are expanding alongside revenue.
The price discounts that trajectory far out. At $333.52 no valuation family reaches the price; the supported range is near $39 with a base in the high $30s. Inverting the price implies sustaining high growth for about 30 years, which is why the reliability flag is low and the rarity check is elevated.
The balance sheet is clean: about $654 million in cash, no debt. There is no financial risk. The bet is entirely on whether the AI-packaging and advanced-node metrology demand that is driving the current acceleration proves as durable as the price assumes.
Bull Case
Lead with the earnings trajectory, because the direction of the numbers is the heart of the bull case. Onto's revenue, margins and growth rate are all accelerating at once. Q1 2026 delivered record revenue of $292 million, nearly 10% sequential growth and above the $275 to $285 million guidance, with EPS of $1.42 ahead of expectations. Management guided Q2 to $320 to $330 million, the midpoint up about 28% year over year, with gross margin of 56% to 56.5%, and framed full-year 2026 revenue growth above 30%. A company posting record quarters, raising the trajectory, and expanding margin into the strength is showing operating momentum, not a one-quarter pop.
The driver behind the momentum is the right one: advanced semiconductor manufacturing. Onto's metrology and inspection systems provide process control across the industry, and the 10-K describes integrating these technologies "to meet our customers' changing process requirements" with tools that provide "process control for the majority of" critical steps (FY2025 10-K, accession 0001193125-26-066937). The specific wins are at the leading edge: the Dragonfly G5 system was qualified at a 2.5D logic customer and a high-bandwidth-memory customer, and the new Atlas G6 was selected by a second logic customer for gate-all-around metrology, helping drive 13% advanced-node growth in the quarter. These are the exact process steps that AI chips and advanced packaging require, and they are growing fastest.
The runway is sized to the AI buildout. Management expects Dragonfly platform demand to grow more than 50% in 2026 and AI device-packaging demand to grow roughly 30% annually over the next two years. Onto sits at a control point in that supply chain, and it does so with a pristine balance sheet: about $654 million in cash and no debt. It can fund R&D and capacity expansion internally while the demand wave builds. A profitable, debt-free metrology leader with accelerating revenue, expanding margins, leading-edge tool wins and a multi-year AI-packaging tailwind is the kind of business whose forward earnings can grow into a rich multiple, which is the bull's answer to a price the static methods call full.
Bear Case
The bear case is about which assumptions are baked into the price and which is most fragile. At $333.52 (June 27, 2026) no valuation family reaches the price, and the implied-expectations read requires sustaining high growth for about 30 years. The price is underwriting two specific narratives: that AI-packaging and advanced-node metrology demand grows at the rates management projects, and that Onto keeps its share of those steps for decades. The most fragile of these is the durability of the AI-driven demand. The current acceleration is real, but it is concentrated in a buildout cycle that, like every semiconductor cycle before it, will eventually digest. A pause in AI capital spending would hit the fastest-growing, highest-expectation part of Onto's business first.
The competitive narrative is the second fragility. Onto names its principal competitors directly: in automated systems for the semiconductor industry, they are "KLA Corporation and Nova Ltd." (FY2025 10-K, accession 0001193125-26-066937). KLA in particular is far larger and dominates process control. Onto's leading-edge tool wins are impressive, but holding and extending share against a much bigger incumbent across a 30-year horizon is a strong assumption to embed in the price. If KLA or Nova contests the gate-all-around or advanced-packaging metrology that is driving Onto's growth, the share gains that justify the multiple could stall or reverse.
The structural reality compounds both. The 10-K is explicit that Onto operates "in the highly concentrated, capital-intensive semiconductor device manufacturing industry" and that "historically, a substantial portion of our revenue in each quarter and year" comes from a small number of customers (same 10-K). Customer concentration means a single large customer's spending decision can swing a quarter, and capital-intensive customers cut tool orders sharply in downturns. Trailing operating margin is around 10%, far below the price's implied steady-state, and the rarity check is elevated with the fade assumption tripped. The bear case is not that Onto is a bad business; it is that the price has discounted three decades of high growth, sustained share against larger rivals, and no cyclical interruption, leaving no margin for the AI narrative to cool or the competitive position to slip.
Valuation
Onto's valuation sits above every method. The blended central estimate is near $42 against a price of $333.52, and no family reaches the price: the asset family values the stock at roughly a tenth of the price, the earnings-power family similarly, the peer-multiple family at about a sixth, and even the forward-growth family well below. The most generous individual reads, a DCF exit multiple near $181 and a discounted future market cap near $78, still fall far short of the price. The supported range runs from about $33 to $48, with low reliability, which tells you the methods agree the price is rich but cannot pin a precise number on a business growing this fast.
The inversion makes the assumption explicit. With trailing operating margin around 10%, backing out the price requires sustaining growth near the high-end ceiling for about 30 years. That is among the longest durations a cyclical capital-equipment business can carry, and the rarity assessment is elevated with the fade check tripped, signaling that such persistence is well outside the base rate. The price is not valuing Onto on its current earnings; it is valuing it on three decades of the AI-packaging and advanced-node growth wave continuing largely uninterrupted and Onto retaining its position throughout.
The balance sheet is a clean positive that does not change the central estimate. About $654 million in cash and no debt mean Onto can invest through any cycle without financial strain, and the share count is flat, so there is no dilution dragging on per-share value. That financial strength is part of why a premium is defensible for a quality metrology leader. What it cannot do is shorten the 30-year duration the price requires or insulate the business from the semiconductor cycle and from competition with KLA and Nova. The methods are unanimous that the price embeds a best-case, long-duration outcome; the investment question is whether conviction in the AI-metrology runway justifies paying a price that every standard frame says is well above the business as it stands today.
Catalysts
Onto Innovation reported record Q1 2026 revenue of $292 million, nearly 10% sequential growth and above the $275 to $285 million guidance, with EPS of $1.42 beating estimates (Q1 2026 earnings release). The quarter was driven by leading-edge wins: the Dragonfly G5 qualified at a 2.5D logic and a high-bandwidth-memory customer, and the Atlas G6 selected by a second logic customer for gate-all-around metrology, helping drive 13% advanced-node growth (Onto IR).
The catalysts ahead are the demand-growth and margin trajectory. Management guided Q2 2026 to $320 to $330 million of revenue, 56% to 56.5% gross margin, and non-GAAP EPS of $1.65 to $1.73, with full-year revenue growth above 30%; it expects Dragonfly demand to grow more than 50% in 2026 and AI device-packaging demand to grow roughly 30% annually over two years (Investing.com). Watch three things over the coming quarters: whether revenue keeps tracking toward the 30%-plus full-year guide, whether gross margin expands as the mix shifts to advanced nodes, and whether new tool qualifications and customer wins keep widening the leading-edge position against KLA and Nova. Sustained advanced-node growth with margin expansion would support the trajectory the price assumes; an AI-spending pause, a competitive loss, or a customer-concentration air pocket would pull the stock back toward the methods, which all sit far below the current price.
Peer Cohorts (Per Segment, With Filing Citations)
Process characterization metrology, inspection, lithography & software (reported)
- KLAC (KLA CORPORATION)
- FY2025 10-K: …Process; and PCB and Component Inspection. Semiconductor Process Control The Semiconductor Process Control segment offers a comprehensive portfolio of inspection, metrology and data analytics products, and related services, which helps IC manufacturers achieve target yield throughout the entire semiconductor…
- FY2025 10-K: …semiconductor manufacturing processes; • Changes in semiconductor manufacturing processes that are extremely costly for our customers to implement and, accordingly, our customers could reduce their available budgets for process control equipment by reducing inspection and metrology sampling rates for certain…
- NVMI (NOVA LTD.)
- FY2025 20-F: …for both dimensions and materials. This provides the most advanced portfolio, combining the best innovative metrology capabilities with the best reliability and return on investment. • The ability to provide a unique and differentiated technology portfolio sets us apart from the competition and adds a competitive…
- FY2025 20-F: …and materials properties in these 3D structures. • Faster Time to Market. The accelerating rate of obsolescence of technology and the faster ramp to yield required by customers makes early achievement of high manufacturing yields a critical component of profitability and metrology has a critical role in achieving…
- CAMT (CAMTEK LTD)
- (no filing in the citation store)
- MKSI (MKS INC)
- FY2025 10-K: …guidance and control for manufacturing processes. In connection with the Atotech Acquisition (as defined below), we introduced an extension of the Surround the Workpiece offering called Optimize the Interconnect®, which refers to MKS' combined laser drilling and chemistry solutions geared towards accelerating…
- FY2025 10-K: 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as soon as reasonably practicable after we electronically file such materials with, or furnish them to, the SEC. Markets and Applications Since our inception, we have focused on satisfying the needs of our customers by establishing…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.